Adding canakinumab to the Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for systemic juvenile idiopathic arthritis: Comment on the article by DeWitt et al

Arthritis Care Res (Hoboken). 2014 Sep;66(9):1430-1. doi: 10.1002/acr.22343.

Authors

Yukiko Kimura¹, Esi Morgan DeWitt, Timothy Beukelman, Matthew L Stoll, Peter A Nigrovic, Karen Onel, Sampath Prahalad, Sheila Angeles-Han, Rayfel Schneider; Juvenile Idiopathic Arthritis Disease-Specific Research Committee of the Childhood Arthritis and Rheumatology Research Alliance

Affiliation

¹ Joseph M. Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, NJ.

PMID: 24719268
DOI: 10.1002/acr.22343

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antirheumatic Agents / therapeutic use*
Arthritis, Juvenile / drug therapy*
Clinical Protocols / standards*
Disease Management*
Female
Humans
Male

Substances

Antirheumatic Agents